Companies in #Pulmonary Hypertension

Kardigan is a clinical-stage cardiovascular biotechnology company founded by Tassos Gianakakos, the former CEO of MyoKardia (acquired by Bristol-Myers Squibb for $13B), with a portfolio of in-licensed cardiovascular drug candidates targeting cardiomyopathies and related heart conditions.

Medical device company developing pulmonary artery denervation technology for the treatment of pulmonary hypertension and related cardiovascular conditions.

United Therapeutics is a biotechnology company focused on developing therapies for pulmonary arterial hypertension and other rare diseases.